iohexol has been researched along with Tuberous Sclerosis in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighteen renal cell carcinomas and 8 other tumours were found; 78 kidneys had cysts, 12 polycystic kidneys and 10 fibrotic kidneys were detected, 20 kidneys showed other findings." | 1.30 | Renal masses--evaluation by amplitude coded colour Doppler sonography and multiphasic contrast-enhanced CT. ( Dörfler, O; Kugler, C; Preidler, K; Riccabona, M; Schreyer, HH; Szolar, D; Uggowitzer, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riccabona, M | 1 |
| Szolar, D | 1 |
| Preidler, K | 1 |
| Uggowitzer, M | 1 |
| Kugler, C | 1 |
| Dörfler, O | 1 |
| Schreyer, HH | 1 |
1 other study available for iohexol and Tuberous Sclerosis
| Article | Year |
|---|---|
Renal masses--evaluation by amplitude coded colour Doppler sonography and multiphasic contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Fema | 1999 |